(TheNewswire)
Vancouver, British Columbia – TheNewswire - March 15, 2022 – Blackhawk GrowthCorp. (CSE:BLR ) ; ( Frankfurt:0JJ) (the “ Company ” or “ Blackhawk ”) ispleased to report that MindBio Therapeutics (“MindBio”) hasco-invested in QuantifiedCitizen’s (quantifiedcitizen.com) latest funding round with other notable investors around the world.The investment was funded from MindBio existing working capital.
Quantified Citizen is a leading mobile health researchplatform with over 52,000 users and over 17,000 participants in theirglobal microdosing study, which was published in the prestigiousscience journal Nature ScientificReports .
MindBio is in the final completion stages of a worldfirst Phase 1 clinical trial microdosing LSD to patients at home.Co-founder of MindBio, Justin Hanka said “We are impressed with theextensive work that Quantified Citizen is doingin decentralized clinical trials and we are excited to invest andparticipate in their journey and to explore synergies in ourrespective microdosing clinical trials. Data is the key todeveloping safe and effective treatment strategies and understandingthe nuances of the effects of psychedelic medicines on patienthealth”.
Quantified Citizen has created an innovative healthtechnology platform that seeks to democratize scientific discoverythrough digitized health measures and a community of professionalresearchers and passionate citizen scientists. “We envision a worldwhere doing scientifically valid health research is as fast and easyas creating a website, with the same global reach. Where scientifictinkering and self-examination are normalized, vastly accelerating thepace of discovery by unlocking unexamined data,” shares co-founderand CEO Eesmyal Santos-Brault.
MindBio is working towards creating a safe andeffective microdosing regimen using psychedelics that can beprescribed by doctors to patients in the primary health care systemwith the aim of changing the course of mental health .
About Blackhawk Growth
Blackhawk is an investment holding company looking tocreate substantial value for its shareholders through the acquisitionand development of high growth companies. It has focused itsinvestments in the health, cannabis and cannabidiol industries in bothCanada and the United States. Its portfolio of companies includes SacPharma, LeichtMind Clinics, Noble Hemp, Spaced Food, Stable Foods Co.,MindBio Therapeutics, Digital Mind Technologies as well as an equityposition in Gaia Grow Corp. (CSE:GAIA).
The Company diligently posts updates through videosfrom the official company YouTube channel https://www.youtube.com/channel/UCs4f2tt3yAvOGhNLjgNOy-A
Please join the conversation on our Blackhawk groupsupporter’s telegram group at https://t.me/Blackhawkgrowthcorp and visit us online at https://www.blackhawkgrowth.com .
For further information please contact:
Frederick Pels, Chief ExecutiveOfficer
(403)-991-7737
fred@ blackhawkgrowth.com
Cautionary NoteRegarding Forward-Looking Statement
All statements in this pressrelease, other than statements of historical fact, are “forward-looking information”with respect to the Company within the meaning of applicablesecurities laws, including with respect to transaction and futureoperations of MindBio Therapeutics Pty Ltd. The Company providesforward-looking statements for the purpose of conveying informationabout current expectations and plans relating to the future andreaders are cautioned that such statements may not be appropriate forother purposes. By its nature, this information is subject to inherentrisks and uncertainties that may be general or specific and which giverise to the possibility that expectations, forecasts, predictions,projections or conclusions will not prove to be accurate, thatassumptions may not be correct and that objectives, strategic goalsand priorities will not be achieved. These risks and uncertaintiesinclude but are not limited those identified and reported in theCompany’s public filings under the Company’s SEDAR profile atwww.sedar.com. Although the Company has attempted to identifyimportant factors that could cause actual actions, events or resultsto differ materially from those described in forward-lookinginformation, there may be other factors that cause actions, events orresults not to be as anticipated, estimated or intended. There can beno assurance that such information will prove to be accurate as actualresults and future events could differ materially from thoseanticipated in such statements. The Company disclaims any intention orobligation to update or revise any forward-looking information,whether as a result of new information, future events or otherwiseunless required by law.
Copyright (c) 2022 TheNewswire - All rights reserved.